Large-scale studies of metabolites (metabolomics) are key to understand cellular metabolism and pathophysiology of human conditions. We sought to characterize metabolic profile changes in maternal and umbilical cord blood in gestations with different clinical phenotypes of fetal smallness.
OBJECTIVE:
Large-scale studies of metabolites (metabolomics) are key to understand cellular metabolism and pathophysiology of human conditions. We sought to characterize metabolic profile changes in maternal and umbilical cord blood in gestations with different clinical phenotypes of fetal smallness.
STUDY DESIGN: Prospective cohort study in singleton term gestations including 28 normally grown fetuses and 52 small fetuses (diagnosed >32 weeks) sub-classified into small for gestational age (SGA) [if birthweight (BW) was between 3 rd and 9 th centile and had a normal fetoplacental Doppler; n¼25] and fetal growth restriction (FGR) (if BW was <3 rd centile and/or abnormal fetoplacental Doppler was present; n¼27). Maternal and cord blood plasma samples were used for NMR-based metabolic fingerprinting and profiling, including analysis of the enrichment of circulating lipid classes and subclasses, as well as the number of sub-fraction particles and their size. RESULTS: Changes in phosphatidylcholines and glycoproteins were prominent in FGR indicating significant alterations in their abundance and biophysical properties (Fig 1) . Lipoprotein profiles showed significantly lower concentrations of cholesterol-intermediate density lipoprotein (IDL) (-17%), triglycerides (TG)-IDL (-13%) and ehigh-density lipoprotein (HDL) (-18%) in mothers of small fetuses (both, SGA and FGR) compared to controls (p<0.05; all). In contrast, growth-restricted fetuses had significantly higher concentrations of cholesterol and TG transporting lipoproteins [LDL (+32%), IDL (+24%), and VLDL (+56%), (p<0.005; all)], as well as increased VLDL particle types (large, medium and small) (Fig 2) . Significant changes in concentrations of formate, histidine, isoleucine and citrate in FGR were also observed. CONCLUSION: Both, mother and fetuses of pregnancies complicated with fetal growth restriction have a substantial disruption in lipid metabolism. SGA and FGR presented a similar pattern of metabolic changes, supporting the notion that they represent different degrees of severity of the same underlying condition.
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The predicted etiology of prenatally diagnosed fetal lung masses is not always consistent with lung mass histology at the time of neonatal resection. Most data to date describe outcomes based on prenatal imaging characteristics. Our aim was to assess obstetric and neonatal outcomes by fetal lung mass histology. STUDY DESIGN: We reviewed all pregnancies complicated by fetal lung mass from a single academic center from [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] [2017] . For the current analysis, only those with prenatal and neonatal data, including final histology data, were included. Maternal demographics, prenatal imaging, obstetric and neonatal outcomes were analyzed and compared between lung mass histologic categories: bronchopulmonary sequestration (BPS) and congenital pulmonary airway malformation (CPAM) subtypes. The primary composite outcome was neonatal respiratory distress defined as any of: continuous positive airway pressure; intubation and mechanical ventilation; extracorporeal membrane oxygenation; or resection of the lung mass before neonatal discharge. RESULTS: Of 60 pregnancies complicated by fetal lung mass during the study period, 43 had prenatal, postnatal, and final histology data. Of those, there were 10 cases of CPAM type 1, 9 cases of CPAM type 2, and 16 cases of BPS. There was 1 case of CPAM type 3, which was not included in the analysis due to low incidence. Maternal age, race/ ethnicity, insurance status, and parity were similar between histologic categories. There was no difference in gestational age at delivery, IUGR, mode of delivery, birthweight, or Apgar scores between groups. PPROM was the only adverse outcome that approached statistical significance (0% in CPAM type 1, 33.3% in CPAM type 2, 6.2% in BPS, p ¼ 0.07). Neonatal respiratory distress was not statistically different between the groups (30.0% in CPAM type 1, 22.2% in CPAM type 2, 43.8% in BPS, p ¼ 0.66), and there was no difference in neonatal length of stay, time to postnatal resection, or neonatal mortality (Table) . CONCLUSION: Final histology of a prenatally diagnosed fetal lung mass may not be associated with different obstetric and neonatal outcomes, including respiratory distress at birth. Our results can inform fetal surveillance and maternal counseling.
